Cargando…
Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Whether SARS-CoV-2 can trigger an autoimmune reaction against platelets and red blood cells remains unclear. Herein, we report a case of COVID-19 pneumonia associated with seve...
Autores principales: | Gruden, Gabriella, Beggiato, Eloise, Camerino, Enrica, Capriotti, Serena, Canepa, Silvia, Scandella, Michela, Avolio, Maria, Pittalunga, Fabrizia, Barutta, Federica, Durazzo, Marilena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082984/ https://www.ncbi.nlm.nih.gov/pubmed/33995989 http://dx.doi.org/10.1177/20406207211011353 |
Ejemplares similares
-
Autoimmune hepatitis treatment in the elderly: A systematic review
por: Durazzo, Marilena, et al.
Publicado: (2019) -
First Report of Severe Autoimmune Hemolytic Anemia During Eltrombopag Therapy in Waldenström Macroglobulinemia-Associated Thrombocytopenia
por: Shen, Yingying, et al.
Publicado: (2021) -
Novel Insight into the Mechanisms of the Bidirectional Relationship between Diabetes and Periodontitis
por: Barutta, Federica, et al.
Publicado: (2022) -
SGLT2 inhibition to address the unmet needs in diabetic nephropathy
por: Barutta, Federica, et al.
Publicado: (2019) -
MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS
por: Barutta, Federica, et al.
Publicado: (2021)